Global IPV Vaccine Market Research Report 2024

Report ID: 1843595 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 IPV Vaccine Market Overview
    1.1 Product Overview and Scope of IPV Vaccine
    1.2 IPV Vaccine Segment by Type
        1.2.1 Global IPV Vaccine Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Mahoney
        1.2.3 MEF1
        1.2.4 Saukett
    1.3 IPV Vaccine Segment by Application
        1.3.1 Global IPV Vaccine Sales Comparison by Application: (2022-2028)
        1.3.2 Private Distribution Channel
        1.3.3 Public Distribution Channel
    1.4 Global IPV Vaccine Market Size Estimates and Forecasts
        1.4.1 Global IPV Vaccine Revenue 2017-2028
        1.4.2 Global IPV Vaccine Sales 2017-2028
        1.4.3 IPV Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 IPV Vaccine Market Competition by Manufacturers
    2.1 Global IPV Vaccine Sales Market Share by Manufacturers (2017-2022)
    2.2 Global IPV Vaccine Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global IPV Vaccine Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers IPV Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 IPV Vaccine Market Competitive Situation and Trends
        2.5.1 IPV Vaccine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest IPV Vaccine Players Market Share by Revenue
        2.5.3 Global IPV Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 IPV Vaccine Retrospective Market Scenario by Region
    3.1 Global IPV Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global IPV Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America IPV Vaccine Market Facts & Figures by Country
        3.3.1 North America IPV Vaccine Sales by Country
        3.3.2 North America IPV Vaccine Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe IPV Vaccine Market Facts & Figures by Country
        3.4.1 Europe IPV Vaccine Sales by Country
        3.4.2 Europe IPV Vaccine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific IPV Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific IPV Vaccine Sales by Region
        3.5.2 Asia Pacific IPV Vaccine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America IPV Vaccine Market Facts & Figures by Country
        3.6.1 Latin America IPV Vaccine Sales by Country
        3.6.2 Latin America IPV Vaccine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa IPV Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa IPV Vaccine Sales by Country
        3.7.2 Middle East and Africa IPV Vaccine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global IPV Vaccine Historic Market Analysis by Type
    4.1 Global IPV Vaccine Sales Market Share by Type (2017-2022)
    4.2 Global IPV Vaccine Revenue Market Share by Type (2017-2022)
    4.3 Global IPV Vaccine Price by Type (2017-2022)
5 Global IPV Vaccine Historic Market Analysis by Application
    5.1 Global IPV Vaccine Sales Market Share by Application (2017-2022)
    5.2 Global IPV Vaccine Revenue Market Share by Application (2017-2022)
    5.3 Global IPV Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 GlaxoSmithKline Plc
        6.1.1 GlaxoSmithKline Plc Corporation Information
        6.1.2 GlaxoSmithKline Plc Description and Business Overview
        6.1.3 GlaxoSmithKline Plc IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 GlaxoSmithKline Plc IPV Vaccine Product Portfolio
        6.1.5 GlaxoSmithKline Plc Recent Developments/Updates
    6.2 Sanofi S.A
        6.2.1 Sanofi S.A Corporation Information
        6.2.2 Sanofi S.A Description and Business Overview
        6.2.3 Sanofi S.A IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Sanofi S.A IPV Vaccine Product Portfolio
        6.2.5 Sanofi S.A Recent Developments/Updates
    6.3 Serum Institute of India Pvt. Ltd.
        6.3.1 Serum Institute of India Pvt. Ltd. Corporation Information
        6.3.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
        6.3.3 Serum Institute of India Pvt. Ltd. IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Serum Institute of India Pvt. Ltd. IPV Vaccine Product Portfolio
        6.3.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
    6.4 PT Bio Farma
        6.4.1 PT Bio Farma Corporation Information
        6.4.2 PT Bio Farma Description and Business Overview
        6.4.3 PT Bio Farma IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 PT Bio Farma IPV Vaccine Product Portfolio
        6.4.5 PT Bio Farma Recent Developments/Updates
    6.5 AJ Vaccines
        6.5.1 AJ Vaccines Corporation Information
        6.5.2 AJ Vaccines Description and Business Overview
        6.5.3 AJ Vaccines IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 AJ Vaccines IPV Vaccine Product Portfolio
        6.5.5 AJ Vaccines Recent Developments/Updates
7 IPV Vaccine Manufacturing Cost Analysis
    7.1 IPV Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of IPV Vaccine
    7.4 IPV Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 IPV Vaccine Distributors List
    8.3 IPV Vaccine Customers
9 IPV Vaccine Market Dynamics
    9.1 IPV Vaccine Industry Trends
    9.2 IPV Vaccine Market Drivers
    9.3 IPV Vaccine Market Challenges
    9.4 IPV Vaccine Market Restraints
10 Global Market Forecast
    10.1 IPV Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of IPV Vaccine by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of IPV Vaccine by Type (2023-2028)
    10.2 IPV Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of IPV Vaccine by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of IPV Vaccine by Application (2023-2028)
    10.3 IPV Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of IPV Vaccine by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of IPV Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global IPV Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
    Table 2. Global IPV Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
    Table 3. Global IPV Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global IPV Vaccine Market Competitive Situation by Manufacturers in 2021
    Table 5. Global IPV Vaccine Sales (Units) of Key Manufacturers (2017-2022)
    Table 6. Global IPV Vaccine Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global IPV Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global IPV Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market IPV Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers IPV Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers IPV Vaccine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global IPV Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IPV Vaccine as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global IPV Vaccine Sales by Region (2017-2022) & (Units)
    Table 16. Global IPV Vaccine Sales Market Share by Region (2017-2022)
    Table 17. Global IPV Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global IPV Vaccine Revenue Market Share by Region (2017-2022)
    Table 19. North America IPV Vaccine Sales by Country (2017-2022) & (Units)
    Table 20. North America IPV Vaccine Sales Market Share by Country (2017-2022)
    Table 21. North America IPV Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America IPV Vaccine Revenue Market Share by Country (2017-2022)
    Table 23. Europe IPV Vaccine Sales by Country (2017-2022) & (Units)
    Table 24. Europe IPV Vaccine Sales Market Share by Country (2017-2022)
    Table 25. Europe IPV Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe IPV Vaccine Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific IPV Vaccine Sales by Region (2017-2022) & (Units)
    Table 28. Asia Pacific IPV Vaccine Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific IPV Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific IPV Vaccine Revenue Market Share by Region (2017-2022)
    Table 31. Latin America IPV Vaccine Sales by Country (2017-2022) & (Units)
    Table 32. Latin America IPV Vaccine Sales Market Share by Country (2017-2022)
    Table 33. Latin America IPV Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America IPV Vaccine Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa IPV Vaccine Sales by Country (2017-2022) & (Units)
    Table 36. Middle East and Africa IPV Vaccine Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa IPV Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa IPV Vaccine Revenue Market Share by Country (2017-2022)
    Table 39. Global IPV Vaccine Sales by Type (2017-2022) & (Units)
    Table 40. Global IPV Vaccine Sales Market Share by Type (2017-2022)
    Table 41. Global IPV Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global IPV Vaccine Revenue Share by Type (2017-2022)
    Table 43. Global IPV Vaccine Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global IPV Vaccine Sales (Units) by Application (2017-2022)
    Table 45. Global IPV Vaccine Sales Market Share by Application (2017-2022)
    Table 46. Global IPV Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global IPV Vaccine Revenue Share by Application (2017-2022)
    Table 48. Global IPV Vaccine Price by Application (2017-2022) & (US$/Unit)
    Table 49. GlaxoSmithKline Plc Corporation Information
    Table 50. GlaxoSmithKline Plc Description and Business Overview
    Table 51. GlaxoSmithKline Plc IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. GlaxoSmithKline Plc IPV Vaccine Product
    Table 53. GlaxoSmithKline Plc Recent Developments/Updates
    Table 54. Sanofi S.A Corporation Information
    Table 55. Sanofi S.A Description and Business Overview
    Table 56. Sanofi S.A IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Sanofi S.A IPV Vaccine Product
    Table 58. Sanofi S.A Recent Developments/Updates
    Table 59. Serum Institute of India Pvt. Ltd. Corporation Information
    Table 60. Serum Institute of India Pvt. Ltd. Description and Business Overview
    Table 61. Serum Institute of India Pvt. Ltd. IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Serum Institute of India Pvt. Ltd. IPV Vaccine Product
    Table 63. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
    Table 64. PT Bio Farma Corporation Information
    Table 65. PT Bio Farma Description and Business Overview
    Table 66. PT Bio Farma IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. PT Bio Farma IPV Vaccine Product
    Table 68. PT Bio Farma Recent Developments/Updates
    Table 69. AJ Vaccines Corporation Information
    Table 70. AJ Vaccines Description and Business Overview
    Table 71. AJ Vaccines IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. AJ Vaccines IPV Vaccine Product
    Table 73. AJ Vaccines Recent Developments/Updates
    Table 74. Production Base and Market Concentration Rate of Raw Material
    Table 75. Key Suppliers of Raw Materials
    Table 76. IPV Vaccine Distributors List
    Table 77. IPV Vaccine Customers List
    Table 78. IPV Vaccine Market Trends
    Table 79. IPV Vaccine Market Drivers
    Table 80. IPV Vaccine Market Challenges
    Table 81. IPV Vaccine Market Restraints
    Table 82. Global IPV Vaccine Sales Forecast by Type (2023-2028) & (Units)
    Table 83. Global IPV Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 84. Global IPV Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 85. Global IPV Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 86. Global IPV Vaccine Sales Forecast by Application (2023-2028) & (Units)
    Table 87. Global IPV Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 88. Global IPV Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 89. Global IPV Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 90. Global IPV Vaccine Sales Forecast by Region (2023-2028) & (Units)
    Table 91. Global IPV Vaccine Sales Market Share Forecast by Region (2023-2028)
    Table 92. Global IPV Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 93. Global IPV Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of IPV Vaccine
    Figure 2. Global IPV Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Mahoney Product Picture
    Figure 4. MEF1 Product Picture
    Figure 5. Saukett Product Picture
    Figure 6. Global IPV Vaccine Market Share by Application in 2021 & 2028
    Figure 7. Private Distribution Channel
    Figure 8. Public Distribution Channel
    Figure 9. Global IPV Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global IPV Vaccine Market Size (2017-2028) & (US$ Million)
    Figure 11. Global IPV Vaccine Sales (2017-2028) & (Units)
    Figure 12. IPV Vaccine Sales Share by Manufacturers in 2021
    Figure 13. Global IPV Vaccine Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest IPV Vaccine Players: Market Share by Revenue in 2021
    Figure 15. IPV Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global IPV Vaccine Sales Market Share by Region (2017-2022)
    Figure 17. Global IPV Vaccine Sales Market Share by Region in 2021
    Figure 18. Global IPV Vaccine Revenue Market Share by Region (2017-2022)
    Figure 19. Global IPV Vaccine Revenue Market Share by Region in 2021
    Figure 20. United States IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Colombia IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Turkey IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Saudi Arabia IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. UAE IPV Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Sales Market Share of IPV Vaccine by Type (2017-2022)
    Figure 44. Manufacturing Cost Structure of IPV Vaccine
    Figure 45. Manufacturing Process Analysis of IPV Vaccine
    Figure 46. IPV Vaccine Industrial Chain Analysis
    Figure 47. Channels of Distribution
    Figure 48. Distributors Profiles
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline Plc
Sanofi S.A
Serum Institute of India Pvt. Ltd.
PT Bio Farma
AJ Vaccines
Frequently Asked Questions
IPV Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
IPV Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
IPV Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports